Parabilis Medicines, Inc.(PBLS)

Biotechnology · Cambridge, MA

$28.67-0.86 (-2.90%)

Delayed quote: Oct 6, 2026, 12:25 PM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T16:28:16.344Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:28:16.344Z.

Quote observation: 2026-10-06T16:25:18.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: N/A
Quote price: 28.6744

FMP input reference: 66afd7ad6fe085f612ae866be6517f9e897c4fba6e73e474a8e5d595bf17d99d

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

PBLS Earnings Yield Metrics

EARNINGS YIELD

N/A

PBLS Competitors' Earnings Yield

PBLS

Parabilis Medicines, Inc.

Current

Market Cap

$3.34B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDNA

CareDx, Inc

vs PBLS

Market Cap

$3.39B

Earnings Yield

3.16%

TTM Avg

5.71%

3Y Avg

6.07%

5Y Avg

6.07%

PLSE

Pulse Biosciences, Inc.

vs PBLS

Market Cap

$3.40B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACAD

Acadia Pharmaceuticals Inc.

vs PBLS

Market Cap

$3.41B

Earnings Yield

11.15%

TTM Avg

8.17%

3Y Avg

6.43%

5Y Avg

6.43%

CELC

Celcuity Inc.

vs PBLS

Market Cap

$3.50B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IDYA

IDEAYA Biosciences, Inc.

vs PBLS

Market Cap

$3.51B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IRTC

iRhythm Technologies, Inc.

vs PBLS

Market Cap

$3.53B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DNLI

Denali Therapeutics Inc.

vs PBLS

Market Cap

$3.12B

Earnings Yield

N/A

TTM Avg

0.44%

3Y Avg

0.44%

5Y Avg

0.44%

RGC

Regencell Bioscience Holdings Limited

vs PBLS

Market Cap

$3.59B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARQT

Arcutis Biotherapeutics, Inc.

vs PBLS

Market Cap

$3.05B

Earnings Yield

0.85%

TTM Avg

0.82%

3Y Avg

0.82%

5Y Avg

0.82%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Parabilis Medicines, Inc. (PBLS)	$3.34B	N/A	N/A	N/A	N/A
CareDx, Inc (CDNA)vs ›	$3.39B	3.16%	5.71%	6.07%	6.07%
Pulse Biosciences, Inc. (PLSE)vs ›	$3.40B	N/A	N/A	N/A	N/A
Acadia Pharmaceuticals Inc. (ACAD)vs ›	$3.41B	11.15%	8.17%	6.43%	6.43%
Celcuity Inc. (CELC)vs ›	$3.50B	N/A	N/A	N/A	N/A
IDEAYA Biosciences, Inc. (IDYA)vs ›	$3.51B	N/A	N/A	N/A	N/A
iRhythm Technologies, Inc. (IRTC)vs ›	$3.53B	N/A	N/A	N/A	N/A
Denali Therapeutics Inc. (DNLI)vs ›	$3.12B	N/A	0.44%	0.44%	0.44%
Regencell Bioscience Holdings Limited (RGC)vs ›	$3.59B	N/A	N/A	N/A	N/A
Arcutis Biotherapeutics, Inc. (ARQT)vs ›	$3.05B	0.85%	0.82%	0.82%	0.82%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

PBLS Earnings Yield Metrics

PBLS Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics